Cytokine profiles in the sera of Egyptian patients with oral pemphigus vulgaris

Brazilian Journal of Oral Sciences

Volumn 10, Issue 2, 2011, Pages 83-87

  Eid, Hossam ^a   El Gamal, Basiouny ^b  

^a Suez Canal University   (Egypt)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Cytokines; Oral lesions; Pemphigus vulgaris

Indexed keywords

EID: 79960449183     PISSN: 16773217     EISSN: 16773225     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. D'Auria L, Bonifati A, Mussi A, D'Agosto G, De Simone C, Giacalone, et al. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytok Netw. 1997; 8: 383-7.
2. Narbutt J, Lukamowicz J, Bogaczewicz J, Sysa-Jedrzejowska A, Torzecka JD, Leslak A. Serum concentrations of interleukin-6 is increased both in active and remission stages of Pemphigus vulgaris. Mediators Inflamm. 2008; 2008: 875-94.
3. Stern JNH, Keski n DB, Barteneva N, Zuniga J, Yunis EJ, Ahmed AR. Possible role of natural killer cells in Pemphigus vulgaris - preliminary observations. Clin Exp Immunol. 2008; 15: 472-81.
4. Raychaudhuri SP, Smriti K. Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases. Ind J Dermatol. 2009; 54: 100-9.
5. Femiano F. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis. Minerva Stomatol. 2007; 56: 215-23.
6. Yamamoto T, Yoneda K, Ueta E. Serum cytokine levels in patients with oral mucous membrane disorders. J Oral Pathol Med. 1991; 20: 275-9.
7. Shanmugasekar C, Ram Gaesh VR, Jayaramun A, Srinivas CR. Blister fluid immunofluorescence in case of pemphigus vulgaris. Ind J Dermatol. 2010; 55: 188-9.
8. Mignogna MD, Lorenzolo M, Robert C. Oral pemphigus: Long term behaviour and clinical response to treatment with deflazacort in sixteen cases. J Oral Surg Pathol Med. 2000; 29: 145-52.
9. Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris. Immunol Invest. 2009; 38: 498-509.
10. Baroni A, Perfetto B, Ruocco E, Greco R, Criscuolo D, Ruocco V. Cytokine pattern in blister fluid and sera of patients with pemphigus. Dermatology. 2002; 205: 116-21.
11. Keskin DB, Stern JN, Fridkis-Hareli M, Razzaque Ahme A. Cytokine profiles in pemphi-gus vulgaris patients treated with intravenous Igs as compared to controlled immunosuppressive therapy. Cytokine. 2008; 4: 15-21.
12. Feliciani C, Toto P, Amerio P, Pour SM, Coscione G, Shivji G, et al. In vitro and in vivo expression of interleukin-1-alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1-alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol. 2002; 114: 71-7.
13. Lopez-Robles E, Avalos-Diaz E, Vega-Memije E, et al. TNFá and IL-6 are mediators in the blistering process of pemphigus. Int J Dermatol. 2001; 40: 185-8.
14. Ahmed AR, Yunis EJ, Kharti K, Wagner R, Notani G, Awdeh Z, et al. Major histocompatibility complexhaplotype in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci. 1990; 87: 7658-62.
15. Brenner S, Tur E, Shapio J, Ruocco V, A'avino M, Ruocco E, et al. Pemphigus vulgaris: environmental factors, occupational, behavioral, medical and frequently quetionnaire. Int J Dermatol. 2001; 40: 562-9.
16. John C, Robinson MA, Lozada F. Oral pemphigus vulgaris. Oral Surg Oral Med Oral Pathol. 1997; 84: 349-55.
17. Tetsuya Y, Kazunori Y, Osaki T. Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol. 1994; 78: 727-35.
18. Alecu M, Alecu S, Coman G, Galatescu E, Ursaciuc C. TNF-á and IL-6 in serum and blister liquid of pemphigus vulgaris patients. Roumanian. Arch Microbiol Immunol. 1999; 58: 121-30.
19. Gomi T, Shiohara T, Munakata T, Imanishi K, Nagashima M. Interleukin 1á, tumor necrosis factor á, and interferon ã in psoriasis. Arch Dermatol. 1991; 127: 827-30.
20. Kantor TV, Friberg D, Medsger TA, Jr, Buckingham RB, Whiteside TL. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol. 1992; 65: 278-85.
21. Kock A, Schwarz T, Kimbauer R, Urbanski A, Perry P, Ansel JC, et al. Human keratinocytes are a source for tumor necrosis factor á: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 1990; 172):1609-14.
22. Sugermann NW, Savage GJ, Seymour L. Is there a role for tumor necrosis factor-alpha (TNF-á) in oral lichen planus? J Oral Pathol Med. 1996; 25: 219-24.
23. Takeuchi Y, Tohani I, Kaneda T. Immuno-histochemical analysis of cells in mucosal lesions of lichen planus. J Oral Pathol Med. 1988; 17: 367-71.
24. Farthing PM, Thornhill MH. IL-1 á and IL-6 production by oral and skin keratinocytes: similarities and differences in response to cytokine treatment in vitro. J Oral Pathol Med. 1996; 25: 157-62.
25. Wilson M, Reddi, Henderson B. Cytokine-inducing components of periodonto-pathogenic bacteria. J Priodont Res. 1996; 31: 393-407.
26. Yamamoto T, Osaki T, Ueta K. Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J Oral Pathol Med. 1994; 23: 309-15.